Key facts
- This page summarizes Carrie Ann Nichol's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Oct 2021, 18:03.
Carrie Ann Nichol - 01 Oct 2021 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Reporting relationship
- VP, Controller & CAO
- Issuer ticker
- ZBH
- Reported as of
- 01 Oct 2021
- Net transaction value
- -$7,726
- SEC form
- 4
- Accepted by SEC
- 04 Oct 2021, 18:03:14 UTC
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Heather J. Kidwell, Attorney-in-Fact for Carrie Ann Nichol (power of attorney previously filed)
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Carrie Ann Nichol filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 04 Oct 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$7,726.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZBH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +164
- Change %
- +73%
- Price
- $0.000000
- Shares after
- 390
- Date
- 01 Oct 2021
- Ownership
- Direct
- Footnotes
- F1
ZBH
transaction
Common Stock
Tax liability
- Transaction value
- $7,726
- Shares
- -52
- Change %
- -13%
- Price
- $148.57
- Shares after
- 338
- Date
- 01 Oct 2021
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZBH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -164
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 327
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 164
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Includes 114 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between December 31, 2020 and June 30, 2021.
Footnote F2
Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
Footnote F3
Each RSU represents a contingent right to receive one share of the Company's common stock.
Footnote F4
164 RSUs vested on each of October 1, 2020 and October 1, 2021. Half of the remaining 327 RSUs vest on each of October 1, 2022 and October 1, 2023.